Randy Ringold

 

Randy Ringold

Veterinary Diagnostics Institute (VDxI), a California corporation, is a veterinary clinical ventures company dedicated to the introduction of innovative biomarkers for companion animals.  Through collaboration with academia and in-vitro diagnostics manufacturers, VDxI addresses a growing demand in the veterinary healthcare service for advanced diagnostics.  The United States has the world’s largest population of companion animals, almost 200 million, with over $22 billion spent on veterinary care each year.  For more information see www.vetdiag.com.

About Randy Ringold Randy Ringold is President and Founder of Veterinary Diagnostics Institute (VDxI), a company dedicated to the development and clinical testing of innovative biomarkers for the companion animal market.  Mr. Ringold is also General Manager of Glycominds Laboratory, a CLIA certified laboratory, specializing in unique biomarkers in the field of auto-immune diseases.  Prior to establishing VDxI in 2006, Mr. Ringold was Vice President, WW Sales and Marketing at Nichols Institute, a division of Quest Diagnostics, leading to expand the global presence of esoteric testing throughout the US, Europe, Japan, and Latin America.  Mr. Ringold has degrees in biology and chemistry with a Masters degree in business. 

Veterinary Diagnostics Institute